标题
Neuroblastoma
作者
关键词
-
出版物
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Volume 48, Issue 3, Pages 214-241
出版商
Oxford University Press (OUP)
发表日期
2018-01-22
DOI
10.1093/jjco/hyx176
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients
- (2017) K.C.J.M. Kraal et al. EUROPEAN JOURNAL OF CANCER
- Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project
- (2017) Mark A. Applebaum et al. EUROPEAN JOURNAL OF CANCER
- Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement
- (2017) Matthew J. Ferris et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma
- (2017) Daniel von Allmen et al. JOURNAL OF CLINICAL ONCOLOGY
- Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting
- (2017) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Prolonged Isotretinoin in Ultra High-Risk Neuroblastoma
- (2017) Thomas Cash et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants
- (2017) Amy E. Armstrong et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma
- (2017) Anne Stone et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
- (2017) Rajen Mody et al. LANCET ONCOLOGY
- Chemoimmunotherapy for high-risk neuroblastoma
- (2017) Brian H Kushner LANCET ONCOLOGY
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
- (2017) Ruth Ladenstein et al. LANCET ONCOLOGY
- High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients
- (2017) J Pan et al. LEUKEMIA
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
- (2017) Valentina Boeva et al. NATURE GENETICS
- Proton beam therapy for olfactory neuroblastoma
- (2017) Naoki Nakamura et al. RADIOTHERAPY AND ONCOLOGY
- Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
- (2017) Lars Wagner et al. OncoTargets and Therapy
- Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
- (2017) Jiangtao Ren et al. Protein & Cell
- Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma
- (2016) A V Desai et al. BONE MARROW TRANSPLANTATION
- First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium
- (2016) Frank M. Balis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
- (2016) Annette Künkele et al. CLINICAL CANCER RESEARCH
- The 1p36 Tumor Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis
- (2016) Shuijie Li et al. DEVELOPMENTAL CELL
- Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
- (2016) Maja Olsson et al. Epigenetics
- KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma
- (2016) Christopher J. Forlenza et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
- (2016) Steven G. DuBois et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan
- (2016) Akiko Ioka et al. JOURNAL OF EPIDEMIOLOGY
- Neuroblastoma Mass Screening—What Can We Learn From It?
- (2016) Kota Katanoda JOURNAL OF EPIDEMIOLOGY
- Retinoic Acid for High-risk Neuroblastoma Patients after Autologous Stem Cell Transplantation – Cochrane Review
- (2016) F. Peinemann et al. KLINISCHE PADIATRIE
- Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
- (2016) John T. Powers et al. NATURE
- Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis?
- (2016) Akihiro Yoneda et al. PEDIATRIC SURGERY INTERNATIONAL
- Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies
- (2016) Erika A. Newman et al. Seminars in Pediatric Surgery
- Evidence-based paediatric surgical oncology
- (2016) Paul D. Losty Seminars in Pediatric Surgery
- Complications in the surgical management of children with malignant solid tumors
- (2016) Andrew M. Davidoff et al. Seminars in Pediatric Surgery
- CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases
- (2016) Faheem Ahmed Khan et al. Oncotarget
- Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
- (2016) Vito Alessandro Lasorsa et al. Oncotarget
- Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma
- (2016) Shunpei Satoh et al. Scientific Reports
- The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection
- (2016) Raja Rajalingam Frontiers in Immunology
- Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival
- (2016) Nikolai Siebert et al. OncoImmunology
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- NCYM promotes calpain-mediated Myc-nick production in human MYCN-amplified neuroblastoma cells
- (2015) Wataru Shoji et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- 131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study
- (2015) Gregory A. Yanik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Local control in metastatic neuroblastoma in children over 1 year of age
- (2015) Maria Antonietta De Ioris et al. BMC CANCER
- Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
- (2015) C Pasqualini et al. BONE MARROW TRANSPLANTATION
- Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
- (2015) S G DuBois et al. BRITISH JOURNAL OF CANCER
- Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma
- (2015) Karin Melanie Cabanillas Stanchi et al. CANCER BIOLOGY & THERAPY
- A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
- (2015) Robert W. Schnepp et al. CANCER CELL
- Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells
- (2015) S. M. Rafiqul Islam et al. CANCER SCIENCE
- Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas
- (2015) Yoshiki Kaneko et al. CANCER SCIENCE
- Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric Malignancies
- (2015) Y. P. Mosse CLINICAL CANCER RESEARCH
- MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges
- (2015) Tarek Shalaby et al. CURRENT CANCER DRUG TARGETS
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma
- (2015) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan
- (2015) Shigehisa Fumino et al. JOURNAL OF PEDIATRIC SURGERY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
- (2015) Linda J Valentijn et al. NATURE GENETICS
- Upfront treatment of high-risk neuroblastoma with a combination of131I-MIBG and topotecan
- (2015) Kathelijne C.J.M. Kraal et al. PEDIATRIC BLOOD & CANCER
- Value of surgical resection in children with high-risk neuroblastoma
- (2015) Brian R. Englum et al. PEDIATRIC BLOOD & CANCER
- Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers
- (2015) Yasser Elborai et al. PEDIATRIC TRANSPLANTATION
- COX/mPGES-1/PGE2pathway depicts an inflammatory-dependent high-risk neuroblastoma subset
- (2015) Karin Larsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
- (2015) Daniel R. Carter et al. Science Translational Medicine
- Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
- (2015) Daiki Kayano et al. TheScientificWorldJOURNAL
- A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing
- (2015) Malvina Prapa et al. Oncotarget
- Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin
- (2015) Brian H. Kushner et al. Oncotarget
- Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
- (2015) Daiki Kayano et al. Scientific World Journal
- PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
- (2015) Alessandra Dondero et al. OncoImmunology
- Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2immunotherapy and isotretinoin: a prospective Phase II study
- (2015) Brian H Kushner et al. OncoImmunology
- Immunotherapy of Childhood Sarcomas
- (2015) Stephen S. Roberts et al. Frontiers in Oncology
- Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma
- (2015) Nathan F. Moore et al. Oncotarget
- Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: High incidence of endocrine and growth problems
- (2014) L E Cohen et al. BONE MARROW TRANSPLANTATION
- Drugging MYCN through an Allosteric Transition in Aurora Kinase A
- (2014) William Clay Gustafson et al. CANCER CELL
- The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
- (2014) Gaurav Kumar Pandey et al. CANCER CELL
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Trim32 Facilitates Degradation of MYCN on Spindle Poles and Induces Asymmetric Cell Division in Human Neuroblastoma Cells
- (2014) H. Izumi et al. CANCER RESEARCH
- High Expression of CAI2, a 9p21-Embedded Long Noncoding RNA, Contributes to Advanced-Stage Neuroblastoma
- (2014) L. M. Barnhill et al. CANCER RESEARCH
- Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation
- (2014) Kotaro Ohnishi et al. CELL
- Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
- (2014) A. Oberthuer et al. CLINICAL CANCER RESEARCH
- Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
- (2014) John Maher CURRENT GENE THERAPY
- Likelihood of Bone Recurrence in Prior Sites of Metastasis in Patients With High-Risk Neuroblastoma
- (2014) Alexei L. Polishchuk et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prostaglandin E2promotesMYCNnon-amplified neuroblastoma cell survivalviaβ-catenin stabilization
- (2014) Sepp R. Jansen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study
- (2014) Virginie F. Viprey et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up Results of the Observation Program for Neuroblastoma Detected at 6-Month Mass Screening
- (2014) Ayumu Arakawa et al. JOURNAL OF PEDIATRICS
- Rare Variants in TP53 and Susceptibility to Neuroblastoma
- (2014) Sharon J. Diskin et al. JNCI-Journal of the National Cancer Institute
- Effects of a Novel Long Noncoding RNA, lncUSMycN, on N-Myc Expression and Neuroblastoma Progression
- (2014) Pei Y. Liu et al. JNCI-Journal of the National Cancer Institute
- The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential
- (2014) Himisha Beltran MOLECULAR CANCER RESEARCH
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- MicroRNAs in Neuroblastoma: Small-Sized Players with a Large Impact
- (2014) Feng Zhi et al. NEUROCHEMICAL RESEARCH
- Dexmedetomidine and hydromorphone: A novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children
- (2014) Matthias Görges et al. PEDIATRIC BLOOD & CANCER
- Going back to class I: MHC and immunotherapies for childhood cancer
- (2014) Kellie B. Haworth et al. PEDIATRIC BLOOD & CANCER
- Does Aggressive Surgical Resection Improve Survival in Advanced Stage 3 and 4 Neuroblastoma? A Systematic Review and Meta-analysis
- (2014) Dhanya Mullassery et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
- (2014) Mike-Andrew Westhoff et al. PLoS One
- Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS-ERK Signaling
- (2014) M. Will et al. Cancer Discovery
- NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas
- (2014) Yusuke Suenaga et al. PLoS Genetics
- Platinum compounds in children with cancer
- (2013) Antonio Ruggiero et al. ANTI-CANCER DRUGS
- Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience
- (2013) G A Hale et al. BONE MARROW TRANSPLANTATION
- Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group
- (2013) Larry L. Wang et al. CANCER
- Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
- (2013) Markus Brockmann et al. CANCER CELL
- Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma
- (2013) Tasnim Ara et al. CANCER RESEARCH
- A Multicenter, First-in-Pediatrics, Phase 1, Pharmacokinetic and Pharmacodynamic Study of Ridaforolimus in Patients with Refractory Solid Tumors
- (2013) L. Gore et al. CLINICAL CANCER RESEARCH
- New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK
- (2013) G. Barone et al. CLINICAL CANCER RESEARCH
- Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study
- (2013) J.A. Kohler et al. EUROPEAN JOURNAL OF CANCER
- Toxicity of upfront 131I-metaiodobenzylguanidine (131I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
- (2013) Gitta Bleeker et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dependence receptor UNC5D mediates nerve growth factor depletion–induced neuroblastoma regression
- (2013) Yuyan Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of Surgery in the Treatment of Patients With Stage 4 Neuroblastoma Age 18 Months or Older at Diagnosis
- (2013) Thorsten Simon et al. JOURNAL OF CLINICAL ONCOLOGY
- Ultrahigh-risk Group Within the High-risk Neuroblastoma Category
- (2013) Ulla M. Saarinen-Pihkala et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Acute Pain Relief After Mantram Meditation in Children With Neuroblastoma Undergoing Anti-GD2 Monoclonal Antibody Therapy
- (2013) Mahiuddin Ahmed et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
- (2013) Susan G Kreissman et al. LANCET ONCOLOGY
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
- (2013) Yael P Mossé et al. LANCET ONCOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Long-term follow-up of the thyroid gland after treatment with131I-Metaiodobenzylguanidine in children with neuroblastoma: Importance of continuous surveillance
- (2013) S.C. Clement et al. PEDIATRIC BLOOD & CANCER
- Proton versus photon radiation therapy for patients with high-risk neuroblastoma: The need for a customized approach
- (2013) Christine Hill-Kayser et al. PEDIATRIC BLOOD & CANCER
- Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas
- (2013) N. Ikegaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas
- (2013) Hiroshi Fuji et al. Radiation Oncology
- Clinical results of proton beam therapy for advanced neuroblastoma
- (2013) Yoshiko Oshiro et al. Radiation Oncology
- ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma
- (2013) Md. Kamrul Hasan et al. Scientific Reports
- Neuroblastoma and MYCN
- (2013) M. Huang et al. Cold Spring Harbor Perspectives in Medicine
- A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants
- (2012) Jed G. Nuchtern et al. ANNALS OF SURGERY
- Ifosfamide, carboplatin, and etoposide for neuroblastoma
- (2012) Brian H. Kushner et al. CANCER
- 1p36 Tumor Suppression--A Matter of Dosage?
- (2012) K.-O. Henrich et al. CANCER RESEARCH
- NLRR1 Enhances EGF-Mediated MYCN Induction in Neuroblastoma and Accelerates Tumor Growth In Vivo
- (2012) S. Hossain et al. CANCER RESEARCH
- Mechanisms of CHD5 Inactivation in Neuroblastomas
- (2012) H. Koyama et al. CLINICAL CANCER RESEARCH
- Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
- (2012) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- Combination of an Allosteric Akt Inhibitor MK-2206 with Etoposide or Rapamycin Enhances the Antitumor Growth Effect in Neuroblastoma
- (2012) Z. Li et al. CLINICAL CANCER RESEARCH
- Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastoma
- (2012) THORSTEN SIMON et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience
- (2012) Marion Strullu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Successful treatment of infants with localized neuroblastoma based on their MYCN status
- (2012) Tomoko Iehara et al. International Journal of Clinical Oncology
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
- (2012) Douglas R. Strother et al. JOURNAL OF CLINICAL ONCOLOGY
- N-myc and Noncoding RNAs in Neuroblastoma
- (2012) J. Buechner et al. MOLECULAR CANCER RESEARCH
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Targeting ALK in neuroblastoma—preclinical and clinical advancements
- (2012) Erica L. Carpenter et al. Nature Reviews Clinical Oncology
- Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
- (2012) Julie R. Park et al. PEDIATRIC BLOOD & CANCER
- Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: A Pediatric Oncology Group study: A Report from the Children's Oncology Group
- (2012) Meaghan Granger et al. PEDIATRIC BLOOD & CANCER
- Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?
- (2012) S. Zwaveling et al. PEDIATRIC SURGERY INTERNATIONAL
- Evidence of asymmetric cell division and centrosome inheritance in human neuroblastoma cells
- (2012) H. Izumi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma
- (2012) Y. H. Chanthery et al. Science Translational Medicine
- Neonatal neuroblastoma
- (2012) Jonathan P.H. Fisher et al. Seminars in Fetal & Neonatal Medicine
- Increasing the Clinical Efficacy of NK and Antibody-Mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Based on Observations in High-Risk Neuroblastoma
- (2012) Tony A. Koehn et al. Frontiers in Pharmacology
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
- (2011) Thorsten Simon et al. BMC CANCER
- EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
- (2011) C. Wang et al. CANCER RESEARCH
- Expression of NLRR3 Orphan Receptor Gene Is Negatively Regulated by MYCN and Miz-1, and Its Downregulation Is Associated with Unfavorable Outcome in Neuroblastoma
- (2011) J. Akter et al. CLINICAL CANCER RESEARCH
- Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
- (2011) S. J. Shuttleworth et al. CURRENT MEDICINAL CHEMISTRY
- ATP-Competitive Inhibitors of mTOR: An Update
- (2011) S. Schenone et al. CURRENT MEDICINAL CHEMISTRY
- MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas
- (2011) Ruimin Huang et al. FASEB JOURNAL
- Proton Radiotherapy for High-Risk Pediatric Neuroblastoma: Early Outcomes and Dose Comparison
- (2011) Jona A. Hattangadi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study
- (2011) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Local control, survival, and operative morbidity and mortality after re-resection, and intraoperative radiation therapy for recurrent or persistent primary high-risk neuroblastoma
- (2011) Barrie S. Rich et al. JOURNAL OF PEDIATRIC SURGERY
- I-131-MIBG therapies
- (2011) Stefan Vöö et al. METHODS
- A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours
- (2011) Benjamin Beck et al. NATURE
- Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1
- (2011) Eriko Isogai et al. PLoS One
- Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
- (2011) Hervé J. Brisse et al. RADIOLOGY
- Immunology and immunotherapy of neuroblastoma
- (2011) Robert C. Seeger SEMINARS IN CANCER BIOLOGY
- Targeting Angiogenesis for Controlling Neuroblastoma
- (2011) Subhasree Roy Choudhury et al. Journal of Oncology
- Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial
- (2010) C Jubert et al. BONE MARROW TRANSPLANTATION
- Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation
- (2010) S Ash et al. BRITISH JOURNAL OF CANCER
- Genotypes of NK Cell KIR Receptors, Their Ligands, and Fc Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy
- (2010) D. C. Delgado et al. CANCER RESEARCH
- Global genomic and RNA profiles for novel risk stratification of neuroblastoma
- (2010) Miki Ohira et al. CANCER SCIENCE
- Oncogenic mutations of ALK in neuroblastoma
- (2010) Seishi Ogawa et al. CANCER SCIENCE
- Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma
- (2010) Maria Antonietta De Ioris et al. EUROPEAN JOURNAL OF CANCER
- An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells
- (2010) Manuele Castelnuovo et al. FASEB JOURNAL
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase 1 Study of Nifurtimox in Patients With Relapsed/Refractory Neuroblastoma
- (2010) Giselle L. Saulnier Sholler et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Mortality and morbidity of patients with neuroblastoma who survived for more than 10 years after treatment—Niigata Tumor Board Study
- (2010) Masayuki Kubota et al. JOURNAL OF PEDIATRIC SURGERY
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- Asymmetric cell division: recent developments and their implications for tumour biology
- (2010) Juergen A. Knoblich NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bβ and TSLC1 in neuroblastoma
- (2010) H Ochiai et al. ONCOGENE
- PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis
- (2010) A Bender et al. ONCOGENE
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
- (2010) H. Caren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- Graft versus neuroblastoma reaction is efficiently elicited by allogeneic bone marrow transplantation through cytolytic activity in the absence of GVHD
- (2009) Shifra Ash et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of ALK Signaling for Cancer Therapy
- (2009) Y. P. Mosse et al. CLINICAL CANCER RESEARCH
- KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
- (2009) J. M. Venstrom et al. CLINICAL CANCER RESEARCH
- Excellent Local Control From Radiation Therapy for High-Risk Neuroblastoma
- (2009) Heather G. Gatcombe et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Poor Survival for Infants WithMYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
- (2009) Adela Canete et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma WithoutMYCNGene Amplification
- (2009) Bruno De Bernardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Secular Trends in Neuroblastoma Mortality Before and After the Cessation of National Mass Screening in Japan
- (2009) Kota Katanoda et al. JOURNAL OF EPIDEMIOLOGY
- Nifurtimox Induces Apoptosis of Neuroblastoma Cells In Vitro and In Vivo
- (2009) Giselle L. Saulnier Sholler et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study
- (2009) Caroline Laverdière et al. JNCI-Journal of the National Cancer Institute
- Copy number variation at 1q21.1 associated with neuroblastoma
- (2009) Sharon J. Diskin et al. NATURE
- Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
- (2009) Mario Capasso et al. NATURE GENETICS
- KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors
- (2009) Antonio Pérez-Martínez et al. PEDIATRIC BLOOD & CANCER
- HIF-2 maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
- (2009) A. Pietras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures
- (2008) R Ladenstein et al. BONE MARROW TRANSPLANTATION
- Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
- (2008) B De Bernardi et al. BRITISH JOURNAL OF CANCER
- Hypoxia-Inducible Factor-2α Transactivates Abcg2 and Promotes Cytoprotection in Cardiac Side Population Cells
- (2008) Cindy M. Martin et al. CIRCULATION RESEARCH
- Targeting the Phosphoinositide 3-Kinase Isoform p110 Impairs Growth and Survival in Neuroblastoma Cells
- (2008) D. Boller et al. CLINICAL CANCER RESEARCH
- Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age
- (2008) Jan de Kraker et al. EUROPEAN JOURNAL OF CANCER
- Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma
- (2008) Lizzia Raffaghello et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- The kinesin KIF1B acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
- (2008) S. Schlisio et al. GENES & DEVELOPMENT
- Expression ofTSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation
- (2008) Kiyohiro Ando et al. INTERNATIONAL JOURNAL OF CANCER
- KIF1Bβ Functions as a Haploinsufficient Tumor Suppressor Gene Mapped to Chromosome 1p36.2 by Inducing Apoptotic Cell Death
- (2008) Arasambattu K. Munirajan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Significance ofMYCNAmplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database
- (2008) Rochelle Bagatell et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Rare Occurrence of PHOX2b Mutations in Sporadic Neuroblastomas
- (2008) Alexandre Serra et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- CHD5 , a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas
- (2008) Tomoyuki Fujita et al. JNCI-Journal of the National Cancer Institute
- Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study
- (2008) Eiso Hiyama et al. LANCET
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
- Mechanisms of asymmetric cell division: flies and worms pave the way
- (2008) Pierre Gönczy NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma
- (2008) John M. Maris et al. NEW ENGLAND JOURNAL OF MEDICINE
- N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma
- (2008) M S Hossain et al. ONCOGENE
- Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: A report from the Children's Oncology Group
- (2008) Julie R. Park et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More